Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

Summary

RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well irinotecan works in treating young patients with refractory or recurrent hepatoblastoma.

Timeline

Start

2003-04

Primary completion

2008-12

Completion

—

Drugs

Indications